In the present study, the mean and median LOX expression levels were lower in ER negative vs. positive tumours, however, there was a clearly separated subgroup of ∼14% ER negative patients with considerably higher LOX expression levels than all other ER negatives. Here, ESR1 is linked to neoplasm.